Pillstats
Rx only · Tablet · Sublingual

Buprenorphine

Buprenorphine Hydrochloride

13 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US29 NDCs
13 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1819
US makers13 labelers
Packages64
DEA / ScheduleCIII

US acquisition costNADAC · per unit

Average across 14 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.142$0.284$0.426$0.567Dec 2025Apr 2026Jul 2026
$0.417
Latest avg · Jul 22, 2026
-16%
Since Dec 17, 2025
13
Active US suppliers
67%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

92K184K275K367K2025 Q12025 Q22025 Q32025 Q42026 Q1
265K
Rx · 2026 Q1
12.6M
Units dispensed
-13%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it13 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager39SUPPLYING
Clinical Solutions Wholesale, LLCunknown4SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown4SUPPLYING
Major Pharmaceuticalsunknown2SUPPLYING
Unit Dose Solutions, Inc.unknown2SUPPLYING
AvPAKunknown2SUPPLYING
Rhodes Pharmaceuticals LLCunknown2SUPPLYING
Actavis Pharma, Inc.unknown2SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown2SUPPLYING
American Health Packagingunknown2SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING
Redpharm Drugunknown1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • May 3, 2023
    RECALLRecall (Class II): Buprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun Pharma, NDC 62756-460-83.

    CGMP Deviations — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Product was distributed to 19 distributors nationwide.